Navigation Links
MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
Date:8/14/2008

iffer materially from those anticipated. The words, "believe," "expect," "intend," "anticipate," and variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward- looking. Statements in this announcement that are forward-looking include, but are not limited to, statements about the Company's product development and commercialization schedule, including, particularly, future plans with respect to its Amoxicillin PULSYS products; any statements regarding Dr. Rudnic's comments and expectations concerning the Company; the Company's initiatives to develop improved antibiotics; the Company's existing and anticipated collaborative agreements; and any financial forecasts and projections for 2008 and thereafter included under the Financial Guidance section of this announcement.

The actual results realized by MiddleBrook could differ materially from these forward-looking statements, depending in particular upon the risks and uncertainties described in the Company's filings with the Securities and Exchange Commission. These include, without limitation, risks and uncertainties relating to the Company's financial results and the ability of the Company to (1) raise additional capital and continue as a going concern, (2) maintain its Keflex 750 sales, (3) retain marketing approval for its MOXATAG product, (4) successfully reduce costs, (5) reach profitability, (6) prove that the preliminary findings for its product candidates are valid, (7) receive required regulatory approvals, (8) successfully conduct clinical trials in a timely manner, (9) establish its competitive position for its products, (10) develop and commercialize products that are superior to existing or newly developed competitor products, (11) develop products without any defects, (12) have sufficient capital resources to fund its operations, (13) protect its intellectual property rights and patents, (14) implement its
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
2. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
3. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
4. MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
5. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
6. Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results
7. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
8. MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results
9. Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
10. ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update
11. Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... 2014 Over the past 39 years, ... hundreds of emergency departments across the nation, from quality ... been translated into an innovative suite of tools, systems, ... and enhance the patient experience. , NES Health, ... and management services for hospitals, announced the development and ...
(Date:12/21/2014)... December 21, 2014 As testosterone ... heart attacks, stroke and blood clots from using testosterone ... a new study shows that the male hormone testosterone ... In a study published in the Proceedings of the ... Amos-Landgraf examined a group of male rats with naturally ...
(Date:12/21/2014)... 21, 2014 Concept Plus, LLC. a ... headquartered in Fairfax, VA., today announced it has been ... 50 list, which ranks the fastest growing government contracting small ... to 2013. , This is the first year that Concept ... # 20 with a 95.92% compound annual growth rate. “For ...
(Date:12/20/2014)... MissyDress, a distinguished special dress supplier, ... The business has drastically cut prices to all its ... until Jan. 30, 2015. Many of the hottest styles ... dresses, lace dresses, and more. , A spokesman for ... day. Whether A-line princess prom dresses or sweetheart chiffon ...
(Date:12/20/2014)... 2014 Dress company LunaDress has recently announced ... its Christmas Sale, offering big discounts on all of its ... an idea to own a perfect wedding gown. If you ... dress, then come to LunaDress. Many different wedding dress styles ... our website now and enjoy the current special offer, up ...
Breaking Medicine News(10 mins):Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2
... Eating Disorders Reports Eating Disorders Develop or ... Worsen Upon Returning to ... Disorders, http://www.remudaranch.com, the nation,s leading eating disorder treatment,center, reports ... majority of eating disorders begin at ages 14 and 18, ...
... Non-English Speaking Patients ... ... GetWellNetwork, Inc., a leading,provider of Interactive Patient Care (IPC) solutions, ... with the,company,s PatientLife System(R). With this release, GetWellNetwork sets a,new ...
... to All Iowa ... Communities, ... of the Iowa State Police Association, the Partnership for a,Drug-Free America, ... community outreach program designed to,raise awareness and reduce demand for the ...
... Oct. 10 The Attention Deficit Disorder,Association (ADDA) ... 8 million adults,who live with Attention Deficit/Hyperactivity Disorder ... and the negative stigma surrounding this,disorder, 85 percent ... family and other relationships and educational and,employment problems. ...
... in mice need to be repeated in humans, experts ... say they,ve made new strides in harnessing the body,s ... sclerosis. , According to the U.S. team, a single ... mice repaired myelin, the protective sheath that covers nerves. ...
... Scientists at the U.S. Department of Energy,s Brookhaven ... the results of microscopic imaging techniques in a ... and possibly treatment of a variety of disease ... a U.S. provisional patent application for the invention. ...
Cached Medicine News:Health News:Going Back to School Can Trigger Eating Disorders 2Health News:Going Back to School Can Trigger Eating Disorders 3Health News:GetWellNetwork Expands Foreign Language Support for the PatientLife System 2Health News:GetWellNetwork Expands Foreign Language Support for the PatientLife System 3Health News:GetWellNetwork Expands Foreign Language Support for the PatientLife System 4Health News:Partnership for a Drug-Free America and Council Bluffs Police Department Introduce Methamphetamine Prevention Program to Iowa Law Enforcement 2Health News:Partnership for a Drug-Free America and Council Bluffs Police Department Introduce Methamphetamine Prevention Program to Iowa Law Enforcement 3Health News:ADDA Kicks Off AD/HD Awareness Campaign with Regional Meeting on Oct. 20 in Atlanta, GA 2Health News:Antibody Helps Repair MS Nerve Damage 2Health News:Microgrid allows simultaneous study of multiple variables 2
(Date:12/19/2014)... HILL, N.C. , Dec. 19, 2014 /PRNewswire/ ... innovative consumer research and marketing communication tools are ... and globally competitive – consequently consumers, desires, preferences, ... In this environment, market research groups across all ... and marketing communication tools. However, the adoption of ...
(Date:12/19/2014)... 2014 Somewhere between dropping five pounds and ... But Audicus , a next-generation hearing aids company, ... year. Hearing loss is the third most ... it is often unaddressed. Forty-eight million Americans have hearing ... aid, mainly due to price. Hearing aids traditionally cost ...
(Date:12/19/2014)... 2014 Capnia, Inc. (NASDAQ: ... diagnostics based on its proprietary Sensalyze™ Technology Platform ... financial results for the third quarter and nine ... the completion of our initial public offering (IPO), ... recently initiated CoSense® commercial launch," said Anish Bhatnagar, ...
Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Audicus Will Help People Resolve to Hear Better in 2015 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8
... OSAKA, Japan, Aug. 22 Hospira Japan Co., Ltd. ... long-term (greater than 24 hour) use of the sedative ... Hospira,s first launches earlier this year of Precedex in ... as the company continues to build the molecule,s global ...
... SILVER SPRING, Md., Aug. 20 The Food and Drug ... products, including "Miracle Mineral Supplement," which acts ... consumed as directed stolen asthma inhalers, which may be ... as an herbal weight-loss supplement that contains prescription drug ingredients, ...
Cached Medicine Technology:Hospira Japan Receives Approval for New Indication for 'Precedex IV™ 200ug' 2Hospira Japan Receives Approval for New Indication for 'Precedex IV™ 200ug' 3Hospira Japan Receives Approval for New Indication for 'Precedex IV™ 200ug' 4FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: July 2010 2
Modular flow cytometer with all options....
... Compact mobile flow cytometer for ... absolute volumetric counting. The CyFlow SL ... in combination with up to 3 ... real-time display is performed with a ...
The Cytomics FC 500 Series delivers flexible testing, powerful software and a user-friendly interface features that help researchers optimize their overall workflow efficiency while maintaining true ...
... 1000 immunoassay system features an extensive ... hardware and excellent assay performance. The ... accommodates onboard dilutions, positive sample identification, ... IMMULITE 1000 (and its predecessor, the ...
Medicine Products: